Lucas W. Buchanan - 16 Nov 2021 Form 4 Insider Report for Silk Road Medical Inc

Role
COO/CFO
Signature
/s/Mhairi Jones, by power of attorney
Issuer symbol
N/A
Transactions as of
16 Nov 2021
Net transactions value
-$455,900
Form type
4
Filing time
17 Nov 2021, 18:37:06 UTC
Previous filing
29 Oct 2021
Next filing
14 Jan 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SILK Common Stock Options Exercise $47,300 +10,000 +5.6% $4.73 189,997 16 Nov 2021 Direct F1
transaction SILK Common Stock Sale $503,200 -10,000 -5.3% $50.32 179,997 16 Nov 2021 Direct F1, F2
holding SILK Common Stock 13,518 16 Nov 2021 Buchanan Grandchildren's Irrevocable Trust F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SILK Option (right to buy) Options Exercise $0 -10,000 -51% $0.000000 9,744 16 Nov 2021 Common Stock 10,000 $4.73 Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option exercise and sale reported on this Form 4 were effected pursuant to Rule 10b5-1 Trading Plan adopted by the reporting person on September 3, 2021.
F2 This transaction was executed in multiple trades at price ranging from $50.00 to $50.64. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F3 These shares are held directly by the Buchanan Grandchildren's Irrevocable Trust, for which the Reporting Person serves as a co-trustee.
F4 All of the shares subject to this option are fully vested and exercisable as of the date hereof.